Document is current
Any future updates will be listed below
-
Authors
Gaberino, Courtney L. https://orcid.org/0000-0002-2383-760X
Segnitz, R. Max https://orcid.org/0000-0001-9806-259X
Dill-McFarland, Kimberly A. https://orcid.org/0000-0003-1481-7065
Bacharier, Leonard B.
Calatroni, Agustin
Gill, Michelle A.
Stokes, Jeffrey
Liu, Andrew H.
Cohen, Robyn T.
Kumar, Rajesh
Lang, Abigail https://orcid.org/0000-0002-0186-691X
Khurana Hershey, Gurjit K. https://orcid.org/0000-0001-6663-977X
Sherenian, Michael G.
Zoratti, Edward M.
Teach, Stephen J.
Kattan, Meyer
Becker, Patrice M. https://orcid.org/0000-0002-1170-8587
Togias, Alkis
Busse, William W. https://orcid.org/0000-0003-2591-4696
Jackson, Daniel J.
Altman, Matthew C.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5UM1AI114271, UM1AI160040, UM2AI117870, T32AI007635)
U.S. Department of Health & Human Services | National Institutes of Health (UL1TRG01422, UL1 TR002535, UL1RR025741, UL1TR000150, UL1TR001422, UL1TR001876, 5UL1TR001425–03)
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 22 August 2025
First Online: 2 September 2025
Competing interests
: All authors, with the exceptions of P.M.B. and A.T. report grants from the US National Institutes of Health (NIH)–NIAID during the study. P.M.B. and A.T. have nothing to disclose outside of the submitted work. L.B.B. reports personal fees from GlaxoSmithKline, Genentech–Novartis, Teva, Boehringer Ingelheim, AstraZeneca, WebMD–Medscape, Merck, DBV Technologies, Circassia, Sanofi–Regeneron, and Vectura, all outside the submitted work. M.C.A. reports personal fees from Sanofi–Regeneron, outside the submitted work. W.W.B. reports consulting fees and payment from GlaxoSmithKline, Sanofi and Regeneron and royalties from Elsevier outside the submitted work. M.A.G. reports monetary compensation from the American Academy of Pediatrics for her work teaching the biannual Pediatrics board review course: PREP The Course. G.K.K.H. reports grants from Adare during the study. D.J.J. reports personal fees from Genentech, Pfizer, Sanofi, Avillion, AstraZeneca and Areteia as well as grants and personal fees from GlaxoSmithKline, Regeneron and OM Pharma, outside the submitted work. M.K. reports personal fees from Regeneron, outside the submitted work. A.H.L. reports personal fees from Phadia ThermoFisher as consulting honoraria; grants and non-financial support from ResMed–Propeller Health; non-financial support from Revenio; grants and personal fees from Avillion; and personal fees from Labcorp, all outside the submitted work. S.J.T. reports grants from NIH–Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH–NHLBI, and EJF Philanthropies and personal fees from Uptodate, all outside the submitted work. All other authors declare no competing interests.
